FDA Cracks Down on “Bad Actors” in Dietary Supplement Market
FDA Cracks Down on “Bad Actors” in Dietary Supplement Market
The agency sends warning letters to makers of products that claim to prevent or treat Alzheimer’s and other diseases, and announces changes to its enforcement practices.
FDA Cracks Down on “Bad Actors” in Dietary Supplement Market
FDA Cracks Down on “Bad Actors” in Dietary Supplement Market

The agency sends warning letters to makers of products that claim to prevent or treat Alzheimer’s and other diseases, and announces changes to its enforcement practices.

The agency sends warning letters to makers of products that claim to prevent or treat Alzheimer’s and other diseases, and announces changes to its enforcement practices.

marketing
Startups Plan the Health Data Gold Rush
Startups Plan the Health Data Gold Rush
Shawna Williams | Oct 1, 2018
Companies are building platforms based on blockchain technology to let individuals control and directly profit from their genomic and medical information.
No Regulatory Exemption for Gene-Edited Products in EU<strong>&nbsp;</strong>
No Regulatory Exemption for Gene-Edited Products in EU 
Catherine Offord | Jul 25, 2018
The European Court of Justice has decided that organisms made with precision techniques such as CRISPR will be subject to the same rules as transgenic plants or animals.
How Safe Is Your Medicine Cabinet?
How Safe Is Your Medicine Cabinet?
Megan Scudellari | May 1, 2013
After numerous high-profile safety scares, clinicians and regulators push to fix critical weaknesses in the FDA’s monitoring system for approved drugs.
Opinion: Celebrities Pushing Drugs?
Howard Brody | Jan 30, 2012
Celebrity spokespeople for pharma companies can manipulate the public’s understanding of disease.